Adamas to Present at Upcoming William Blair Biotech Focus Conference
08 Luglio 2021 - 10:02PM
Business Wire
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated
to developing and delivering medicines that make a meaningful
difference to people affected by neurological diseases, today
announced that Neil F. McFarlane, Chief Executive Officer, will
participate in a fireside chat at the William Blair Biotech Focus
Conference 2021 on Thursday, July 15, 2021 at 1:00 pm Eastern
Time.
The fireside chat will be broadcast live from the investor
relations section of the Adamas website at
http://ir.adamaspharma.com/events-presentations. Replays of the
event will be available for 30 days.
About Adamas Pharmaceuticals, Inc.
At Adamas our vision is clear – to deliver innovative medicines
that reduce the burden of neurological diseases on patients,
caregivers and society. We are a fully-integrated company focused
on growing a portfolio of therapies to address a range of
neurological diseases. For more information, please visit
www.adamaspharma.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210708005682/en/
Media: Sarah Mathieson Vice President, Corporate
Communications 510-450-3528 smathieson@adamaspharma.com
Investors: Peter Vozzo Managing Director Westwicke/ICR
443-213-0505 peter.vozzo@westwicke.com
Grafico Azioni Adamas Pharmaceuticals (NASDAQ:ADMS)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Adamas Pharmaceuticals (NASDAQ:ADMS)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Adamas Pharmaceuticals Inc (NASDAQ): 0 articoli recenti
Più Adamas Pharmaceuticals, Inc. Articoli Notizie